Increased IL-17A was observed in patients with sepsis-induced acute respiratory distress syndrome; IL-17 antibody administration could relieve acute lung injury symptoms by affecting RORγt level and the PI3K pathway. The gene discussed is IL17A; the disease is acute respiratory distress syndrome.